Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q4 FY2025 (2025-12-31): -117.36.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 2 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:34:00.617Z. Historical observations retain their original dates. Historical series through 2024-09-30.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-24.78
EARNINGS PER SHARE (EPS) AVG 3Y
156.25
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NewGenIvf Group Limited
Market Cap
$6197.00
Earnings Per Share (EPS)
N/A
TTM Avg
-24.78
3Y Avg
156.25
5Y Avg
N/A
Market Cap
$30509.00
Earnings Per Share (EPS)
N/A
TTM Avg
-110.58
3Y Avg
-60.80
5Y Avg
-49.51
Market Cap
$62952.00
Earnings Per Share (EPS)
N/A
TTM Avg
-459.91
3Y Avg
-720819.96
5Y Avg
-483554.38
Market Cap
$71682.00
Earnings Per Share (EPS)
-11.16
TTM Avg
-405.74
3Y Avg
-2510.68
5Y Avg
-2758.31
Market Cap
$94334.00
Earnings Per Share (EPS)
N/A
TTM Avg
-5.39
3Y Avg
-4.78
5Y Avg
-3.78
Market Cap
$374618.00
Earnings Per Share (EPS)
N/A
TTM Avg
-48.50
3Y Avg
-108.50
5Y Avg
-157.67
Market Cap
$549273.00
Earnings Per Share (EPS)
-54.17
TTM Avg
-34.20
3Y Avg
-18.78
5Y Avg
-13.04
Market Cap
$668838.00
Earnings Per Share (EPS)
-5669.00
TTM Avg
-313854.00
3Y Avg
-213259.50
5Y Avg
-170757.60
Market Cap
$827564.00
Earnings Per Share (EPS)
-11.80
TTM Avg
-236.00
3Y Avg
-263.84
5Y Avg
-205.13
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6197.00 | N/A | -24.78 | 156.25 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | N/A | -110.58 | -60.80 | -49.51 |
| Akanda Corp. (AKAN)vs › | $62952.00 | N/A | -459.91 | -720819.96 | -483554.38 |
| PRF Technologies Ltd. (PRFX)vs › | $71682.00 | -11.16 | -405.74 | -2510.68 | -2758.31 |
| Psyence Biomedical Ltd. (PBM)vs › | $94334.00 | N/A | -5.39 | -4.78 | -3.78 |
| Niki BioSolutions, Inc. (NIKI)vs › | $374618.00 | N/A | -48.50 | -108.50 | -157.67 |
| HCW Biologics Inc. (HCWB)vs › | $549273.00 | -54.17 | -34.20 | -18.78 | -13.04 |
| CDT Equity Inc. (CDT)vs › | $668838.00 | -5669.00 | -313854.00 | -213259.50 | -170757.60 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827564.00 | -11.80 | -236.00 | -263.84 | -205.13 |
| Decoy Therapeutics Inc. (DCOY)vs › | $856468.00 | -29.09 | -56.46 | -589.82 | -783.52 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$42.66
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 151.20 |
| 2024-12-31 | -200.76 |
| 2023-12-31 | 111.92 |
| 2022-12-31 | 562.64 |
| 2021-12-31 | -0.04 |
